Lipid metabolism disorders and thyrotoxicosis-Reference-Cited by-同舟云学术

Lipid metabolism disorders and thyrotoxicosis

Published:2021-01-22 Issue:6 Volume:65 Page:91-97
ISSN:2500-2228
Container-title:Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
language:
Short-container-title:Ross. vestn. perinatol. pediatr.

Author:

Sadykova D. I.¹^ORCID,Susekov A. V.²^ORCID,Leontyeva I. V.³^ORCID,Zakirov I. I.⁴^ORCID,Slastnikova E. S.⁵^ORCID,Galimova L. F.²^ORCID,Sabirova D. R.¹^ORCID,Krinitskaya N. V.²^ORCID

Affiliation:

1. Kazan State Medical University

2. National Medical Research Center of Cardiology

3. Veltischev Research and Clinical Institute for Pediatrics at the Pirogov Russian National Research Medical University

4. Children’s Republican Clinical Hospital

5. Kazan State Medical University; Children’s Republican Clinical Hospital

Abstract

Disorders of lipid metabolism in endocrine diseases are a frequent occurrence in the daily practice of a doctor and usually have secondary nature. In thyrotoxicosis they have normal or decreased level of total cholesterol and low-density lipoproteins. A clinical case of a patient with thyrotoxicosis, hypercholesterolemia and hypertriglyceridemia is presented. The clinical and laboratory results of the study of the child and his parents are presented. DNA testing was conducted to clarify the diagnosis and conduct differential diagnosis of dyslipidemia type. This case shows difficulties in the diagnostic search for the etiology of dyslipidemia and its correction.

Publisher

The National Academy of Pediatric Science and Innovation

Subject

Pediatrics, Perinatology and Child Health

Reference12 articles.

1. Fredrickson D.S., Lees R.S. A system for phenotyping hyperlipoproteinemia. Circulation 1965; 31:321–327. DOI: 10.1161/01.cir.31.3.321

2. Tremblay K., Gaudet D., Khoury E., Brisson D. Dissection of Clinical and Gene Expression Signatures of Familial versus Multifactorial Chylomicronemia. J Endocrine Soc 2020; 4(6): bvaa056, DOI: 10.1210/jendso/bvaa056

3. Moulin P., Dufour R., Averna M., Arca M., Cefalù A.B., Noto D. et al. Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score”. Atherosclerosis 2018; 275: 265–272. DOI: 10.1016/j.atherosclerosis.2018.06.814

4. Rizos C.V., Elisaf M.S., Liberopoulos E.N. Effects of Thyroid Dysfunction on Lipid Profile. Open Cardiovasc Med J 2011; 5: 76–84. DOI: 10.2174/1874192401105010076

5. Troshina E.A., Sviridenko N.Yu., Vanushko V.E., Rumyantsev P.O., Fadeev V.V., Petunina N.A. i dr. Federal'nye klinicheskie rekomendatsii po diagnostike i lecheniyu toksicheskogo zoba Problemy endokrinologii 2014;60(6): 67–77. [Troshina E.A., Sviridenko N.Yu., Vanushko V.Je., Rumyantsev P.O., Fadeev V.V., Petunina N.A. et al. The federal clinical recommendations on diagnostics and treatment of toxic goiter. Problemy endokrinologii 2014; 60(6): 67–77. (in Russ.)] DOI: 10.14341/probl201460667-77

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypercholesterolemia at a young age;Ateroscleroz;2021-08-10